Immunic股票討論區

$Immunic(IMUX.US)$ Immunic Announces Publication of Extended Data From Phase 2 Emphasis Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation

$Annovis Bio(ANVS.US)$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$迪卡斯(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...

$Immunic(IMUX.US)$ Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States
PR Newswire· 1 min ago

$Immunic(IMUX.US)$ Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024

$Immunic(IMUX.US)$ 這個垃圾每天創新底

$Immunic(IMUX.US)$
get the lead out 😜

$Immunic(IMUX.US)$ 一陰穿四線，趕緊跑吧